SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000914208-05-000050
Filing Date
2005-02-15
Accepted
2005-02-15 09:09:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 INDEVUS PHARMACEUTICALS INC feb140513g-29.txt SC 13G 11445
2 JOINT FILING AGREEMENT exhibita13g.txt EX-99 7746
  Complete submission text file 0000914208-05-000050.txt   21109
Mailing Address ONE LEDGEMONT CENTER 99 HAYDEN AVE LEXINGTON MA 02421
Business Address ONE LEDGEMONT CENTER 99 HAYDEN AVE LEXINGTON MA 02421 6178618444
INDEVUS PHARMACEUTICALS INC (Subject) CIK: 0000854222 (see all company filings)

IRS No.: 043047911 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-41015 | Film No.: 05614842
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11 DEVONSHIRE SQUARE LONDON EC2M 4YR ENGLAND
Business Address 11 DEVONSHIRE SQUARE LONDON EC2M 4YR ENGLAND X0 442076263434
AMVESCAP PLC/LONDON/ (Filed by) CIK: 0000914208 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice